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spasm segments compared to non-spasm segments (0.31  0.58 mm2
vs. 0.04  0.01 mm2, p ¼ 0.046). In spasm segments, thrombus was
most frequently located at spasm sites (81%) followed by upstream of
the spasm segments (19%). Thin cap ﬁbroatheroma was mainly seen in
non-spasm segments compared to spasm segments (21.6% vs. 4.7% vs.
p ¼ 0.038). Plaque erosion however, was more prevalent at spasm
segments compared to non-spasm segments (26.0% vs. 6.5%, p ¼
0.008).OCT ﬁndingsTotal
(n [ 123)Spasm
segments
(n [ 77)Non-spasm
segments
(n [ 46) p-valuePlaque Erosion 23 (18.7) 20 (26.0) 3 (6.5) 0.008Location of erosion 0.086Proximal to analyzed site 6 (26.1) 4 (20.0) 2 (66.6)At vasospasm/analyzed site 17 (73.9) 16 (80.0) 1 (33.3)Thrombus 25 (20.3) 21 (27.3) 4 (8.7) 0.019Red thrombus 4 (16.0) 4 (19.0) 0White thrombus 21 (84.0) 17 (81.0) 4 (100.0)Location of thrombus 0.053Proximal to analyzed site 7 (28.0) 4 (19.0) 3 (75.0)At vasospasm/analyzed site 18 (72.0) 17 (81.0) 1 (25.0)Size of thrombusArea of thrombus (mm2) 0.27  0.54 0.31  0.58 0.04  0.01 0.046
Maximal diameter of thrombus (mm) 0.63  0.53 0.68  0.56 0.39  0.08 0.037CONCLUSIONS Compared to non-spasm segments, thrombus and
plaque erosion were more common at spasm segments. These ﬁndings
suggest the potential beneﬁt and treatment role of antiplatelet ther-
apy in VSA.
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BACKGROUND Several investigations revealed that daily glucose
ﬂuctuation has adverse effects on endothelial cells. Moreover, we
reported that it may have an independent contributing factor on
coronary plaque vulnerability. Little is known, however, about its
impact on neointimal growth after stenting in coronary artery disease
(CAD) patients. We aimed to investigate the impact of glucose ﬂuc-
tuation on neointimal growth following everolimus-eluting stent
(EES) implantation.
METHODS This prospective study enrolled 70 consecutive CAD pa-
tients pretreated with adequate lipid-lowering therapy. 46 patients of
them underwent 8-month follow-up optical coherence tomography
after EES implantation. Glucose ﬂuctuation, expressed as mean
amplitude of glycemic excursion (MAGE) was determined by contin-
uous glucose monitoring before percutaneous coronary intervention.
Uniformity of neointimal distribution was evaluated in 3-D by
computing mean neointimal thickness (NIT) within 360 equally
spaced radial sectors for every 1-mm cross-section by OCT analysis 8
months after stenting. In addition, we analyzed % of uncovered struts
at OCT follow-up. No changes were made to any of the medications for
the control of diabetes, lipids, and hypertension.
RESULTS In total, 56 stents were evaluated in 46 patients. MAGE was
signiﬁcantly correlated with maximum NIT and standard deviation of
NIT, representing the roughness of neointima within a whole stent
(Figure). Moreover, higher MAGE was signiﬁcantly associated with the
higher percentage of uncovered struts (Figure). Multiple linear
regression analysis showed MAGE had independently association
with % of uncovered struts and standard deviation of NIT
(standardized coefﬁcient b ¼ 0.566 and 0.381, respectively, both
P < 0.005).CONCLUSIONS Glucose ﬂuctuation may impact the vessel healing
after EES implantation in CAD patients receiving adequate lipid-
lowering therapy. Further investigations should address the rationale
for the early detection and control of glucose ﬂuctuation in the era of
universal statin use for CAD patients.
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BACKGROUND Mechanical properties of a fully bioresorbable poly-
lactide scaffold are inherently different from a permanent metallic
stent. A previous retrospective intravascular ultrasound (IVUS) study
suggested that immediately after the procedure the Absorb scaffold
was more eccentric and asymmetric when compared to a Xience stent.
However, the relationship between the IVUS parameters and clinical
events has not been investigated in the context of a randomized trial.
METHODS In the ABSORB II trial comparing the Absorb scaffold and
the Xience stent in treatment for a de novo coronary artery stenosis,
protocol-mandated IVUS imaging was performed post procedure in
485 patients with 506 lesions (2:1 randomization, Absorb: 330, Xience:
176). The eccentricity index (EI) was calculated as a minimal value of
the quotients (computed per cross section) of the projected minimum
diameter and the projected maximal diameter. The asymmetry index
(AI) was calculated per lesion as (1 –minimum diameter / maximal
diameter throughout a pullback). The stented /scaffold lesions were
categorized into three groups: 1) concentric and symmetric (EI  0.7
[MUSIC criterion] and AI  0.3); 2) concentric and asymmetric (EI  0.7
and AI > 0.3); 3) eccentric and asymmetric (EI < 0.7 and AI > 0.3).
RESULTS The overall results are presented in the Figure. Post-pro-
cedural EI was smaller in the Absorb arm than in the Xience arm
(0.740.07 vs. 0.810.05, p<0.001), while AI was greater in the
Absorb arm (0.330.08 vs. 0.270.06, p<0.001). At 1-year, the MACE
rates were 8.2%, 6.0% and 2.3% in “eccentric/asymmetric” group, the
“concentric/asymmetric” group and the “concentric/symmetric”
group , respectively (p¼0.04).
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dural scaffold/stent area on IVUS was more eccentric and asymmetric
in the Absorb arm than in the Xience arm. At 1 year, MACE tended to
be observed more frequently in the lesions with high eccentricity and
low symmetry for both, Absorb and Xience.
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BACKGROUND The Tryton Side Branch Stent (TrytonMedical, Durham,
N.C), is a dedicated bifurcation bare-metal stent that, used in combination
with a main branch drug-eluting stent (DES), was developed to improve
outcomes and facilitate the treatment of bifurcations lesions.
METHODS The Tryton coronary bifurcation trial, including 704 pa-
tients, randomized patients in a 1:1 fashion to either a treatment
strategy of main branch DES placement and side branch balloon an-
gioplasty (SBBA), or a treatment with Tryton stent placement in
combination with a main branch DES. The current data represents two
pre-speciﬁed sub-studies: a 9-month intravascular ultrasound (IVUS)
sub-study, primarily designed to investigate the occurrence of strut
fractures, and a detailed segmental 9-month three-dimensional
quantitative coronary angiography (3D-QCA) sub-study.
RESULTS Among the 704 patients enrolled in the Tryton trial, 159
(22.6%) and 190 (27.0%) patientswere part of the pre-speciﬁed IVUS and
3D-QCA sub-group analyses, respectively. There were no differences in
the main branch with regard to 9-month minimal lumen area (MLA)
(5.331.37 in Tryton group vs. 5.691.72 mm2 in SBBA group, p¼0.24)
with low neo-intima area in both groups on IVUS. For the distal main
branch, there were no differences between the treatment arms with
regard the RVD, MLD and %DS on 3D-QCA (%DS: 13.3212.67% vs
13.697.92%, p¼0.84). Importantly, in the proximalmain branch, there
were also no differences between both treatment arms with regard to
the RVD and MLD, resulting in low percent diameter stenosis in both
treatment armswhichwere equal between groups (%DS: 9.857.19% vs
8.879.71%, p¼0.50), suggesting the proximal Trytonwithmain branchDES overlap does not negatively inﬂuence the favorable healing of the
DES. In the side branch, there was also no statistical signiﬁcant differ-
ence in MLA between both groups (3.041.02 in Tryton vs.
3.461.15mm2 in SBBA, p¼0.07). On 3D-QCA, no differences inminimal
lumen diameter (MLD) and percentage diameter stenosis (%DS) were
observed between both groups in the side branch (MLD: 1.340.043mm
[Tryton] vs 1.450.31mm [SBBA], p¼0.09). No complete strut fractures
were observed within the Tryton treated side branches.
CONCLUSIONS From this pre-speciﬁed angiographic 3D QCA and ultra-
sound sub-analysis, the use of the Tryton bare-metal stent did not nega-
tively impact the outcomes of the main branch DES. Similar results were
found regarding the 9-monthMLA andMLDof the side branch between the
Tryton stent and the balloon angioplasty strategy. The IVUS SB analyzable
subgroup however represents a relative small fraction of the intended
study population and therefore selection bias may have occurred.
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BACKGROUND Recent studies have demonstrated that myocardial
bridge (MB) can be one of the causes of ischemic chest pain, pre-
sumably attributable to hemodynamic disturbance in the affected
coronary artery. Diastolic-fractional ﬂow reserve (d-FFR) during
dobutamine challenge has been shown to be useful to identify he-
modynamic disturbance related to MB, but it remains unknown how
the morphology of MB affects d-FFR. This study aimed to investigate
possible association between MB-related IVUS parameters and d-FFR.
METHODS In 86 symptomatic MB patients with no signiﬁcant
obstructive epicardial stenosis, IVUS and d-FFR were evaluated in the
left anterior descending arteries. MB was deﬁned by IVUS as an
echolucent muscle band (halo) partially surrounding the artery. In
addition to minimum lumen area (MLA), MB-related IVUS parameters
were assessed including total MB-length, the number of septal
branches within the MB segment, arterial compression (% decrease in
vessel area at systole), and halo (MB) thickness. Using a coronary
pressure wire, d-FFR was measured at rest and during dobutamine
challenge within and distal to MB. Abnormal d-FFR value was deﬁned
as 0.76 during dobutamine challenge within or distal to MB.
RESULTS Among the MB-related parameters, the number of septal
branches within the MB (r¼-0.314, p¼0.0032) and total MB-length
(r¼0.245, p¼0.0229) signiﬁcantly correlated with d-FFR values with
dobutamine challenge, while arterial compression weakly correlated
with d-FFR at rest (r¼-0.268, p¼0.0209) (Figure). MLA and halo
thickness were not signiﬁcantly related to d-FFR during dobutamine
challenge or at rest. Overall, abnormal d-FFR was found in 88% of
the study patients. Stepwise multiple regression analysis revealed
that the increased number of septal branches within the MB was
independently associated with abnormal d-FFR values (r¼-0.314,
p¼0.0032) among all the MB-related IVUS parameters studied.
CONCLUSIONS In patients with symptomatic MB, greater involve-
ment of septal branches in the MB segment appears to lead to more
hemodynamic disturbance during diastole, presumably accounting
for heterogeneous presentation of dynamic ischemia among the MB
patients. Combination of detailed anatomic and physiologic assess-
ments may enhance our understanding of the exact role of MB in
angina patients with no signiﬁcant obstructive epicardial stenosis.
